THE EFFECT OF FASTING AND/OR BODY-WEIGHT REDUCTION ON TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) AND PLASMINOGEN-ACTIVATOR INHIBITOR (PAI-1)

被引:7
|
作者
PETERNEL, P
STEGNAR, M
MAVRI, A
SALOBIRPAJNIC, B
机构
[1] University Medical Centre, Trnovo Hospital of Internal Medicine, Ljubljana
关键词
FAST; WEIGHT REDUCTION; FIBRINOLYTIC ACTIVITY; SERUM LIPIDS;
D O I
10.1016/0268-9499(94)90240-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Ten healthy, physically fit, non-smoking volunteers (9 women, 1 man, aged 22-55, mean 33 years) with normal body weight and blood lipids were included in the study. During a fasting period of 8-21 (mean 16) days they took only drinks and lost 5-12 (mean 7) kg of body weight. Resting and post-20 min upper arm venous occlusion blood samples were obtained 1-2 days before and on the last day of the fast. Fasting did not significantly affect blood lipids. After fasting an increase in testing euglobulin activity (7.4 vs 3.6 mid(-1), p < 0.01), and in tissue-type plasminogen activator (t-PA) activity (215 vs 42 mIU/ml, p < 0.01) was found. A decrease in plasminogen activator inhibitor (PAT) activity (5.5 vs 7.1 IU/ml, p < 0.07) was indicated, while changes in t-PA and PAI-1 antigens were not significant. After the fast fibrinolytic response to venous occlusion was enhanced as observed by greater increase in euglobulin activity (40.4 vs 11.6 min(-1), p < 0.02), t-PA activity (30754 vs 1593 mIU/ml p < 0.01), t-PA antigen (25.9 vs 11.6 ng/ml, p < 0.02), and greater decrease in PAT activity (3.5 vs 0.0 IU/ml, p < 0.01). In ten non-fasting subjects on normal diet, repeated measurements in a period of 13-23 (mean 17) days revealed no significant changes either before or after venous occlusion, It was concluded that in physically fit, non-obese subjects fasting and/or body weight reduction has enhancing effect on resting and post-venous occlusion fibrinolytic activity without significant changes in blood lipids.
引用
收藏
页码:41 / 43
页数:3
相关论文
共 50 条
  • [31] Tissue plasminogen activator (t-PA) and plasminogen activator inhibitor type 1 (PAI-1) in diabetic foot syndrome
    Kulwas, Arleta
    Lisewska, Beata
    Jundzill, Wieslaw
    Ruszkowska, Barbara
    Drewniak, Wanda
    Ruprecht, Zofia
    Gadomska, Grazyna
    Rosc, Danuta
    ADVANCES IN MEDICAL SCIENCES, 2017, 62 (01): : 87 - 91
  • [32] GENE INACTIVATION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR, UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN MICE
    CARMELIET, P
    SCHOONJANS, L
    STASSEN, JM
    KIECKENS, L
    VANNUFFELEN, A
    DEMOL, M
    COLLEN, D
    MULLIGAN, R
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 764 - 764
  • [33] EFFECT OF PAI-1 LEVELS ON THE MOLAR CONCENTRATION OF ACTIVE TISSUE PLASMINOGEN-ACTIVATOR (T-PA) AND T-PA PAI-1 COMPLEX IN PLASMA
    CHANDLER, WL
    TRIMBLE, SL
    LOO, SC
    MORNIN, D
    BLOOD, 1990, 76 (05) : 930 - 937
  • [34] PLASMINOGEN-ACTIVATOR INHIBITOR-1 IS THE PRIMARY INHIBITOR OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN PREGNANCY PLASMA
    JORGENSEN, M
    PHILIPS, M
    THORSEN, S
    SELMER, J
    ZEUTHEN, J
    THROMBOSIS AND HAEMOSTASIS, 1987, 58 (03) : 872 - 878
  • [35] THE STABILITY OF TISSUE PLASMINOGEN-ACTIVATOR (T-PA)
    GAFFNEY, PJ
    TEMPLEMAN, J
    CURTIS, AD
    CAMPBELL, PJ
    THROMBOSIS AND HAEMOSTASIS, 1983, 50 (03) : 650 - 651
  • [36] FIBRIN-SPECIFIC THROMBOLYSIS WITH TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) AND SINGLE CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR
    COLLEN, D
    THROMBOSIS RESEARCH, 1986, : 127 - 127
  • [37] TISSUE-TYPE PLASMINOGEN-ACTIVATOR ANTIGEN AND PLASMINOGEN-ACTIVATOR INHIBITOR IN DIABETES-MELLITUS
    AUWERX, J
    BOUILLON, R
    COLLEN, D
    GEBOERS, J
    ARTERIOSCLEROSIS, 1988, 8 (01): : 68 - 72
  • [38] TISSUE-TYPE PLASMINOGEN-ACTIVATOR, PLASMINOGEN-ACTIVATOR INHIBITOR AND D-DIMER IN MALIGNANCY
    FERNANDEZ, J
    PARAMO, JA
    CUESTA, B
    HERNANDEZ, M
    PALOMA, MJ
    RIFON, J
    ROCHA, E
    BIOCHEMISTRY, BIOLOGICAL FUNCTIONS, GENE REGULATION AND EXPRESSION, 1988, 801 : 329 - 332
  • [39] THE EFFECT OF HYPOXIA DURING EXERCISE ON RELEASE OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA)
    STEGNAR, M
    DOLZAN, N
    HOJNIK, M
    PETERNEL, P
    FIBRINOLYSIS, 1990, 4 : 108 - 109
  • [40] POSTOPERATIVE CHANGES IN PLASMA TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR
    AOKI, K
    NISHINO, N
    BABA, S
    URANO, T
    TAKADA, A
    SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 1994, 24 (12): : 1039 - 1043